[PDF][PDF] Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for …
PG Northup, JC Garcia‐Pagan, G Garcia‐Tsao… - …, 2021 - Wiley Online Library
• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis
X Niu, L Zhu, Y Xu, M Zhang, Y Hao, L Ma, Y Li… - BMC Public Health, 2023 - Springer
Background Alcohol related liver disease (ARLD) is one of the major chronic liver diseases
worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of …
worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of …
Impact of asymptomatic superior mesenteric vein thrombosis on the outcomes of patients with liver cirrhosis
L Wang, X Guo, Z Bai, Y Yin, S Xu, J Pan… - Thrombosis and …, 2022 - thieme-connect.com
Background The impact of asymptomatic superior mesenteric vein (SMV) thrombosis on the
outcomes of cirrhotic patients remains uncertain. Methods Nonmalignant cirrhotic patients …
outcomes of cirrhotic patients remains uncertain. Methods Nonmalignant cirrhotic patients …
[HTML][HTML] Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
M Biolato, M Paratore, L Di Gialleonardo… - World journal of …, 2022 - ncbi.nlm.nih.gov
In recent years, the traditional concept that cirrhosis-related coagulopathy is an acquired
bleeding disorder has evolved. Currently, it is known that in cirrhotic patients, the hemostatic …
bleeding disorder has evolved. Currently, it is known that in cirrhotic patients, the hemostatic …
The safety and efficacy of apixaban (Eliquis) in 5017 post-bariatric patients with 95.3% follow-up: a multicenter study
Background Thromboprophylaxis in bariatric surgery is widely debated; however, few large
articles evaluate treatment plans and their efficacy. Herein, we make the first large-scale …
articles evaluate treatment plans and their efficacy. Herein, we make the first large-scale …
Intraoperative intracardiac thrombus in liver transplantation: A 9‐year retrospective review focusing on treatment and outcomes
E Fagelman, R Wang, A Tomlinson… - Liver …, 2022 - Wiley Online Library
This study characterizes incidence and outcomes surrounding intracardiac thrombosis (ICT)
during liver transplantation over 9 years at a single center before and after the routine use of …
during liver transplantation over 9 years at a single center before and after the routine use of …
[HTML][HTML] Metabolic disorders and risk of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis
J Li, Q Wang, M Yang, X Sun - The Turkish Journal of …, 2022 - ncbi.nlm.nih.gov
Portal vein thrombosis is considered to be an indicator of worse outcomes in patients with
hepatic cirrhosis. More and more evidence shows that metabolic disorders are noticeable …
hepatic cirrhosis. More and more evidence shows that metabolic disorders are noticeable …
[HTML][HTML] Clinical characteristics and predictors of benign portal vein thrombosis in patients with liver cirrhosis: A retrospective single-center study
Portal vein thrombosis (PVT) is a common thrombotic complication of cirrhosis. It can lead to
variceal bleeding and bowel ischemia and also complicate liver transplantation. Identifying …
variceal bleeding and bowel ischemia and also complicate liver transplantation. Identifying …
[HTML][HTML] Trends of readmissions for gastrointestinal bleeding after alcoholic hepatitis: analysis of the nationwide readmission database
Background Alcohol consumption is associated with numerous hepatic manifestations,
including alcoholic fatty liver disease, alcoholic hepatitis (AH), and liver cirrhosis. AH is a …
including alcoholic fatty liver disease, alcoholic hepatitis (AH), and liver cirrhosis. AH is a …
The Early Initiation of Perioperative Anticoagulation Therapy in Cirrhotic Patients with Portal Hypertension After Laparoscopic Splenectomy Plus Esophagogastric …
D Wang, X Chen, L Lv, T Yang, B Huang… - … & Advanced Surgical …, 2023 - liebertpub.com
Background: Portal veinous system thrombosis (PVST) is a common complication after
laparoscopic splenectomy plus esophagogastric devascularization (LSED). Anticoagulation …
laparoscopic splenectomy plus esophagogastric devascularization (LSED). Anticoagulation …